Indication
Allergic dermatitis
Allergic dermatitis is an inflammatory skin condition triggered by an immunologically mediated hypersensitivity reaction following cutaneous contact with, or systemic exposure to, an offending allergen. Read more about Allergic dermatitis
794 drugs 224 manufacturers
Drugs that treat it
Common Allergic dermatitis therapies.
MOMETASONE FUROATE
MOMETASONE FUROATE
TEXACORT (hydrocortisone)
BETAMETHASONE DIPROP AUGMENTED (betamethasone dipropionate/propylene glycol)
BETAMETHASONE DIPROPIONATE (betamethasone dipropionate/propylene glycol)
BETAMETHASONE DIPROPIONATE (betamethasone dipropionate/propylene glycol)
HYDROXYZINE HCL
HYDROXYZINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAllergic dermatitis is an inflammatory skin condition triggered by an immunologically mediated hypersensitivity reaction following cutaneous contact with, or systemic exposure to, an offending allergen.
Affecting pediatric and adult populations across all demographics, it primarily impacts the integumentary system, classically manifesting as a cell-mediated, type IV delayed hypersensitivity response following prior sensitization.
Upon re-exposure, allergen-specific T lymphocytes trigger localized cutaneous inflammation characterized histologically by epidermal spongiosis and dermal perivascular infiltration.
Clinically, acute presentations feature intense pruritus, erythema, edema, and vesiculation, which can progress in chronic stages to scaling, lichenification, and painful fissuring.
- nih.gov
Allergic dermatitis is an inflammatory skin condition triggered by an immunologically mediated hypersensitivity reaction following cutaneous contact with, or systemic exposure to, an offending allergen
- nih.gov
Allergic dermatitis is an inflammatory skin condition triggered by an immunologically mediated hypersensitivity reaction following cutaneous contact with, or systemic exposure to, an offending allergen Affecting pediatric and adult populations across all demographics, it primarily impacts the integumentary system, classically manifesting as a cell-mediated, type IV delayed hypersensitivity response following prior sensitization
- nih.gov
Affecting pediatric and adult populations across all demographics, it primarily impacts the integumentary system, classically manifesting as a cell-mediated, type IV delayed hypersensitivity response following prior sensitization Upon re-exposure, allergen-specific T lymphocytes trigger localized cutaneous inflammation characterized histologically by epidermal spongiosis and dermal perivascular infiltration
- nih.gov
Upon re-exposure, allergen-specific T lymphocytes trigger localized cutaneous inflammation characterized histologically by epidermal spongiosis and dermal perivascular infiltration
- nih.gov
Clinically, acute presentations feature intense pruritus, erythema, edema, and vesiculation, which can progress in chronic stages to scaling, lichenification, and painful fissuring
- nih.gov
Clinically, acute presentations feature intense pruritus, erythema, edema, and vesiculation, which can progress in chronic stages to scaling, lichenification, and painful fissuring
Personalize your experience
Follow Allergic dermatitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.